JOINN BIOLOGICS - Key Persons


Dr. YuXia Feng

Dr. YuXia Feng is our president of both JOINN Laboratories and JOINN Biologics.

John Vuong

Job Titles:
  • Director, QA Validation
John has developed a very strong background in the area of setting up the GMP Manufacturing infrastructure and Quality System at Biotechnologies, Pharmaceuticals, Medical Devices, and CLIA labs during the past 20 years. John brought products from conception through to commercialization and improved manufacturing efficiency. In addition, John has over 20 years experiences in regulated environments successfully leading groups in Manufacturing, Product Transfer, Manufacturing Technical Support, Process Development, QC, Validation, QA and RA. He has provided comprehensive training to onsite staff regarding operational procedures, cGMP and compliance to FDA guidelines and has completed product transfers for Chiron Corporation, Novartis Corporation, Smithkline Beecham Corp, Quest Diagnostics Corp, Thermo Fishers, and Ortho Diagnostics. With Biochemistry degree John brings a unique technical background to the complex environment of GMP Operations.

Tao He - Founder

Job Titles:
  • Co - Founder
  • General Manager
Tao has more than 20 years of experience in the discovery and development of innovative protein and monoclonal antibodies therapy. He has working experience in world renowned pharmaceutical companies, such as Novartis, Wyeth and Pfizer. Dr. He is a subject matter expert and industry leader in developability analysis and protein drug characterization for biologics development. As a team leader, he has led and directly participated in the development of multiple biomacromolecules that have been successfully approved for clinical and commercial development.

Wen-Rong Jiang

Job Titles:
  • VP, Early Development
Wen-Rong has 20 years biopharma industry experience in R&D and is an expert in antibody drug & cellular model development. She was one of the major contributors to several anti-HCV programs advanced into clinical studies (Roche), and led a number of efforts in targeted cancer therapy using ADC, bispecific Ab, T-cell and macrophage redirecting technologies (Pfizer), created an array of cancer cellular models and stable cell lines using various mammalian cell engineering techniques. Wen-Rong established Cell Line Development Function and workflow at JOINN Bio, and has successfully completed multiple stable cell line development client projects.